• Alternariol (AOH): Mechanisms & Assays

  2026-08-25

  Alternariol, also called AOH, is an Alternaria mycotoxin used to study cytotoxicity, apoptosis, hepatic signaling, and cytochrome P450 metabolism. Evidence links AOH exposure with cellular stress and hepatic stellate-cell activation, but in vitro findings do not by themselves establish human dietary risk.

• SIRT4, GDH, and Glutamine Metabolism in Liver Fibrosis

  2026-08-25

  The reference study identifies a SIRT4–GDH metabolic axis that supports glutamine utilization, hepatic stellate cell proliferation, and liver fibrosis. By combining EGCG-mediated GDH inhibition with SIRT4 gain-of-function experiments in cellular and animal models, the authors show that restricting glutamate conversion to α-ketoglutarate can reduce fibrotic progression and clarify a potential metabolic intervention point.

• L1023 Anti-Cancer Compound Library Workflow

  2026-08-24

  Turn a broad oncology screen into a pathway-resolved experiment with 1,164 pre-dissolved compounds spanning kinase, proteostasis, and apoptosis biology. This workflow pairs viability and migration phenotypes with YAP-focused mechanistic assays inspired by recent DHHC9–STRN4 research.

• Isorhamnetin and PI3K/Akt in Oocyte Maturation

  2026-08-24

  The reference study identifies Isorhamnetin as a potential enhancer of porcine oocyte maturation and connects this phenotype with PI3K/Akt pathway activation. Its results suggest that coordinated control of reactive oxygen species, mitochondrial apoptosis, and endoplasmic reticulum stress may improve oocyte quality in vitro, while translation to human fertility remains unproven.

• Super-Enhancer–TGF-β/SMAD3 Axis in LUAD

  2026-08-23

  Zhang et al. identified LINC01977 as a super-enhancer-hijacked long noncoding RNA that reinforces canonical TGF-β/SMAD3 signaling and promotes early-stage lung adenocarcinoma malignancy. Their integrated epigenomic, molecular, cellular, and animal experiments define a feed-forward circuit involving M2-like tumor-associated macrophages, SMAD3, CBP/P300, and ZEB1, providing a mechanistic framework for relapse and metastasis research.

• Topotecan: Pharmacology and Clinical Evidence

  2026-08-22

  The reference review established Topotecan, also known as SKF104864, as a water-soluble camptothecin derivative whose clinical value arises from stabilizing the DNA–topoisomerase I cleavable complex. Its pharmacokinetics, renal clearance, dose-limiting myelosuppression, activity in ovarian and small-cell lung cancers, and potential for combination therapy remain the central translational lessons for cancer research.

• Nicotinamide Riboside Chloride (NIAGEN) Guide

  2026-08-22

  This scenario-based guide explains how Nicotinamide Riboside Chloride (NIAGEN), SKU C7038, can support better-controlled viability, proliferation, cytotoxicity, and stem-cell workflows. It connects NAD+ biology with practical preparation, assay interpretation, and vendor-selection criteria while distinguishing documented product specifications from exploratory applications.

• CX-5461: From Ribosome Stress to Tumor Control

  2026-08-21

  CX-5461 is an RNA polymerase I inhibitor that links ribosomal RNA synthesis stress with DNA damage, mitotic catastrophe, autophagy, and senescence. This translational guide explains how to position CX-5461 in solid tumor research, design mechanism-resolved assays, and evaluate its potential in cisplatin-sensitization strategies.

• N1-Methyl-Pseudouridine-5'-Triphosphate Workflow

  2026-08-20

  Build more stable, translation-ready RNA with a practical workflow for N1-Methylpseudo-UTP incorporation, quality control, and cell-based testing. The approach connects IVT reagent optimization with localized mRNA delivery, including the bladder cancer use case demonstrated in a recent preclinical study.

• Reactive Oxygen Species Assay Kit in Fibrosis

  2026-08-20

  Superoxide is more than a stress marker: it can connect mitochondrial quality control, mitophagy, and fibrotic remodeling. This thought-leadership guide explains how DHE-based ROS detection can strengthen mechanistic validation and translational decision-making in pulmonary fibrosis research.

• Silver Nanoparticles, Ferroptosis, and Liver Inflammation

  2026-08-19

  A Chemosphere study integrates transcriptomic datasets with zebrafish validation to investigate how silver nanoparticles promote liver inflammation through ferroptosis. The work highlights Arrdc3, Txnip, and Egfr as candidate mediators and connects ferroptotic responses with disrupted glucose metabolism and insulin signaling.

• CDK9 inhibitor A3294: Practical Lab Guide

  2026-08-19

  CDK9 inhibitor A3294 provides a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation, P-TEFb inhibition, and HIV-1 propagation inhibition. It is appropriate for defined biochemical and cellular assays, but not for pan-CDK experiments, broad therapeutic conclusions, or prolonged storage of prepared solutions.

• Transcription Termination After WEE1 Inhibition

  2026-08-18

  The 2026 Nucleic Acids Research study shows that transcription termination limits DNA damage caused by WEE1 inhibition, linking read-through transcription to replication-associated genome instability. Its genetic and pharmacological experiments provide a framework for studying transcription–replication conflicts and for designing combination strategies in cancer models.

• Cardamomin, Oxidative Damage, and Ischemic Stroke

  2026-08-18

  This study links cardamomin from Amomum villosum stems and leaves with protection against hydrogen peroxide-induced oxidative damage and permanent cerebral ischemia. Its main contribution is a mechanistic framework connecting MEK/ERK-driven NRF2 activation with suppression of oxeiptosis, parthanatos, DNA injury, and infarct development.

• L1023 Anti-Cancer Compound Library for Cancer Research

  2026-08-17

  The L1023 Anti-Cancer Compound Library provides 1,164 pre-dissolved bioactive compounds for cancer research and high-throughput screening. Its pathway coverage includes BRAF kinase inhibitor research, mTOR signaling pathway studies, proteasome inhibition, epigenetic regulation, and apoptosis, while product specifications define concentration, format, storage, and quality controls.

8365 records 1/558 page Next 12345 下5页 Last page